Bamethan

This classification denotes a beta-adrenergic agonist with the molecular formula C12H19NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y08ZFJ9TFK, chemically known as benzyl alcohol, alpha-((butylamino)methyl)-p-hydroxy- but generally known as bamethan, which bears US NIH Compound Identifier 2292. Bamethan most often comes in base and sulfate forms. European Medicines Agency schedules Bamethan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06096MIG. The term BAMETHAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules bamethan in its Anatomical Therapeutic Chemical (ATC) Classification. BAMETHAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bamethan under HS 29225000 and SITC 51467. As of Q4 2014, BAMETHAN remains the US FDA Preferred Term for this commodity. Bamethan bears US NLM identifiers UMLS ID C0004718 and NCI Concept Code C76116. SMILES: CCCCNCC(C1=CC=C(C=C1)O)O.